Abstract
Brain-derived neurotrophic factor (BDNF) is the most widely distributed neurotrophin in the CNS, where it plays several pivotal roles in synaptic plasticity and neuronal survival. As a consequence, BDNF has become a key target in the physiopathology of several neurological and psychiatric diseases. Recent studies have consistently reported altered levels of BDNF in the circulation (i.e., serum or plasma) of patients with major depression, bipolar disorder, Alzheimers disease, Huntingtons disease and Parkinsons disease. Correlations between serum BDNF levels and affective, cognitive and motor symptoms have also been described. BDNF appears to be an unspecific biomarker of neuropsychiatric disorders characterized by neurodegenerative changes.
Original language | English (US) |
---|---|
Pages (from-to) | 871-887 |
Number of pages | 17 |
Journal | Biomarkers in Medicine |
Volume | 4 |
Issue number | 6 |
DOIs | |
State | Published - Dec 2010 |
Externally published | Yes |
Keywords
- Alzheimer's disease
- amyotrophic lateral sclerosis
- bipolar disorder
- brain-derived neurotrophic factor
- depression
- Huntington's disease
- Parkinson's disease
- plasma
- serum
ASJC Scopus subject areas
- Drug Discovery
- Clinical Biochemistry
- Biochemistry, medical